Hanmi Pharm. Co., Ltd. (KRX:128940)
South Korea · Delayed Price · Currency is KRW 500,000
+13,000 (2.67%)
Last updated: Apr 10, 2026, 2:12 PM KST
Hanmi Pharm. Revenue
In the year 2025, Hanmi Pharm. had annual revenue of 1.55T KRW with 3.48% growth. Hanmi Pharm. had revenue of 432.96B in the quarter ending December 31, 2025, with 23.14% growth.
Revenue
1.55T
Revenue Growth
+3.48%
P/S Ratio
4.10
Revenue / Employee
644.80M
Employees
2,400
Market Cap
6.34T
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.55T | 52.03B | 3.48% |
| Dec 31, 2024 | 1.50T | 4.61B | 0.31% |
| Dec 31, 2023 | 1.49T | 159.34B | 11.97% |
| Dec 31, 2022 | 1.33T | 128.36B | 10.67% |
| Dec 31, 2021 | 1.20T | 127.33B | 11.84% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Yuhan | 2.19T |
| Daewoong | 2.07T |
| GC Biopharma | 1.99T |
| Chong Kun Dang Pharmaceutical | 1.69T |
| Daewoong Pharmaceutical | 1.57T |
| Boryung | 1.02T |
| DongKook Pharmaceutical | 926.88B |
| Ildong Pharmaceutical | 566.93B |